General Information of Drug (ID: DMWO4EI)

Drug Name
Des-Arg10-Leu9-Kallidin Drug Info
Synonyms
71800-37-8; Lys-(des-Arg9, Leu8)-Bradykinin trifluoroacetate salt; Lys-(Des-Arg9,Leu8)-Bradykinin; AC1NSJPW; Lys-[Leu...8...][des-Arg...9...]Bradykinin; des(Arg10, Leu9)-Kallidin; CHEMBL384721; ZINC169731077; CP-0298; [Leu8]des-Arg10-Kallidin (Lys-[Leu8]des-Arg9-Bradykinin); Lys-(des-Arg9, Leu8)-Bradykinin trifluoroacetate salt, &gt
Indication
Disease Entry ICD 11 Status REF
Discovery agent N.A. Investigative [1]
Cross-matching ID
PubChem CID
5310951
TTD Drug ID
DMWO4EI

Molecule(s) Related to This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
B1 bradykinin receptor (BDKRB1) TTG5QIA BKRB1_HUMAN Inhibitor [1]

The Expression Level of Molecule(s) in Normal Tissue of Major ADME-Related Organs

Molecule Molecule Type Gene Name Liver Colon Kidney Small Intestine
B1 bradykinin receptor (BDKRB1) DTT BDKRB1 4.733 4.129 5.703 5.84
Molecule Expression Atlas in Normal Tissue of Major ADME-related organs

The Expression Level of Molecule(s) between Disease Section and Healthy Individual Tissue

The Studied Disease Discovery agent
ICD Disease Classification N.A.
Molecule Name Molecule Type Gene Name p-value Fold-Change Z-score
B1 bradykinin receptor (BDKRB1) DTT BDKRB1 2.86E-01 0.54 0.35
Molecular Expression Atlas between Disease Section and Healthy Individual Tissue

References

1 Development of an efficient and selective radioligand for bradykinin B1 receptor occupancy studies. Bioorg Med Chem Lett. 2004 Dec 20;14(24):6045-8.